Abbonarsi

EUS-guided fine needle biopsy sampling using a novel fork-tip needle: a case-control study - 20/04/17

Doi : 10.1016/j.gie.2016.03.1405 
Pujan Kandel, MD 1, Ghassan Tranesh, MD 2, Aziza Nassar, MD 2, Russell Bingham 1, Massimo Raimondo, MD 1, Timothy A. Woodward, MD 1, Victoria Gomez, MD 1, Michael B. Wallace, MD, MPH 1,
1 Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA 
2 Department of Pathology, Mayo Clinic, Jacksonville, Florida, USA 

Reprint requests: Michael B. Wallace, MD, MPH, Department of Gastroenterology and Hepatology, 4500 San Pablo Road, Jacksonville, FL 32224.Department of Gastroenterology and Hepatology4500 San Pablo RoadJacksonvilleFL 32224

Abstract

Background and Aims

EUS-guided fine needle biopsy (FNB) sampling and FNA are important methods for obtaining core tissues and cytologic aspirates. To improve the specimen quality for pathologic evaluation, a novel EUS-FNB Shark Core (SC) needle has been designed to acquire core tissue during EUS procedures. We compared the histology yield of EUS-FNB sampling using the SC needle (EUS-FNB-SC) to EUS-FNA in patients who had solid pancreatic and nonpancreatic lesions.

Methods

This was a retrospective case-control study design. Between July 2012 and July 2015 all patients who had EUS-FNB-SC and EUS-FNA were reviewed through a hospital EUS database. Consecutive samples from EUS-FNB-SCs were matched in a 1:3 ratio by lesion site (eg, pancreatic head) and needle gauge (ie, 19 gauge, 22 gauge, 25 gauge) to recent random samples of EUS-FNA. The procedures were performed with rapid onsite evaluation. For study purposes specimen slides were evaluated by 2 cytopathologists for histologic yield using a standard scoring system (0 = no material, 1-2 = cytologic, 3-5 = histologic). The main objectives were to assess the histologic yield of the samples and compare the median number of passes required to obtain core tissue by using EUS-FNB-SC and EUS-FNA needles.

Results

Of the 156 patients included in study, 25% patients (n = 39) were in the EUS-FNB-SC group and 75% (n = 117) in the EUS-FNA group. According to standard scoring criteria for histology, the median histology score for EUS-FNA was 2 (sufficient for cytology but not histology) and for EUS-FNB-SC was 4 (sufficient for adequate histology). Ninety-five percent of the specimens obtained from the EUS-FNB-SC group were of sufficient size for histologic screening, compared with 59% from the EUS-FNA group (P = .01). The median number of passes required to achieve a sample was significantly lower in the EUS-FNB-SC group compared with the EUS-FNA group (2 passes vs 4 passes, P = .001). There was significant difference in the median number of passes to all lesion sites and needle gauges.

Conclusions

The histology yield was significantly higher using the EUS-FNB-SC needle compared with the EUS-FNA needle. Additionally, fewer passes were required to obtain histology cores when using EUS-FNB-SC.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : EUS-FNA, EUS-FNB, EUS-TNB, EUS-FNB-SC, ROSE


Mappa


 DISCLOSURE: The following author disclosed financial relationships relevant to this publication: M. B. Wallace: Consultant for Olympus Corp.; grant support from Boston Scientific and Cosmo Pharmaceuticals. All other authors disclosed no financial relationships relevant to this publication.


© 2016  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 84 - N° 6

P. 1034-1039 - dicembre 2016 Ritorno al numero
Articolo precedente Articolo precedente
  • The PEG-Pedi-PEG technique: a novel method for percutaneous endoscopic gastrojejunostomy tube placement (with video)
  • Jason B. Samarasena, Nathaniel H. Kwak, Kenneth J. Chang, John G. Lee
| Articolo seguente Articolo seguente
  • Impact of EUS-guided fine-needle biopsy sampling with a new core needle on the need for onsite cytopathologic assessment: a preliminary study
  • Eduardo Rodrigues-Pinto, Sujai Jalaj, Ian S. Grimm, Todd H. Baron

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.